R2 Technologies collaborated with Gener8 to develop the F1 Dermal Cooling System, a next-generation device building upon R2’s existing C2 system. The project aimed to enhance aesthetics, usability, and global scalability without altering the core internal components, thereby reducing costs and development time. Through close collaboration, extensive user research, and engineering precision, the F1 system achieved market success, blending elegant design with reliable performance for dermatology applications.
Minimal Mechanical Changes: Needed to upgrade aesthetics and functionality without modifying the internal system architecture.
Global Scalability: Adapt the product to meet international standards and market needs.
Enhanced User Experience: Improve ergonomics and usability for clinicians.
Regulatory Compliance: Meet FDA 510(k), 21 CFR 820.30, and ISO 13485 requirements.
Design Constraints: Integrate a new, polished exterior over an existing mechanical substructure.
Secure System Design: Protect treatment data and prevent unauthorized system access.
Manufacturing Transition: Shift from NPI to scalable manufacturing while managing supply chain complexities.
Industrial Design Integration: Developed an attractive, brand-consistent design while preserving the internal structure.
User and Market Research: Conducted interviews and research to inform ergonomic and aesthetic decisions.
Ergonomic Improvements: Enhanced handpiece design and device mobility for operator comfort.
Engineering Enhancements:
Refined thermoelectric cooling system for precise treatment control.
Modular design for easy servicing and reduced downtime.
Updated GUI for intuitive user interaction.
EMI/EMC compliance for US and China markets.
Collaborative Development: Maintained constant feedback loops between designers, engineers, and stakeholders.
Global Manufacturing Strategy: Supported scalable production with consideration of sites like Costa Rica.